Assignee
SHENZHEN NEOCURA BIOTECHNOLOGY CORP
CN·1 granted patent·6 pending applications·0 citations·filing 2020–2021
Top patents by PatentIndex Score
7 records- 0150US11967399B2Method and system for calculating tumor neoantigen burdenSHENZHEN NEOCURA BIOTECHNOLOGY CORP·Filed 2021·Granted Apr 23, 2024·0 cites·4 claims
- 0245US2021061870A1Method and system for extracting neoantigens for immunotherapySHENZHEN NEOCURA BIOTECHNOLOGY CORP·Filed 2020·Application pending·0 cites
- 0343US2021310010A1Plasmid Vector for Expressing mRNA in Vitro, Construction Method and Application ThereofSHENZHEN NEOCURA BIOTECHNOLOGY CORP·Filed 2020·Application pending·0 cites
- 0441US2022028487A1Deep learning-based method for predicting binding affinity between human leukocyte antigens and peptidesSHENZHEN NEOCURA BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 0539US2021299058A1Intracellular Delivery System for mRNA Nucleic Acid Drugs, Preparation Method and Application ThereofSHENZHEN NEOCURA BIOTECHNOLOGY CORP·Filed 2020·Application pending·0 cites
- 0637US2021057043A1Tumor neoantigen prediction platform and application thereof in neoantigen vaccine development systemSHENZHEN NEOCURA BIOTECHNOLOGY CORP·Filed 2020·Application pending·0 cites
- 0737US2021363589A1Immunotherapy using multi-omics data to extract microsatellite instability-based neoantigenSHENZHEN NEOCURA BIOTECHNOLOGY CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHENZHEN NEOCURA BIOTECHNOLOGY CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →